文献速递前列腺癌

主动监测中因分级升级触发的前列腺癌根治术与新诊断相似级别疾病患者根治术后的生化复发无生存比较

Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease.
PubMed 文献 · J Urol · 2017-03-24

该回顾性研究比较了主动监测中因分级升级至Gleason 7(3+4)或更高(分级组≥2)而接受根治性前列腺切除术的患者与新诊断相似级别疾病立即行根治术患者的生化复发。结果显示主动监测组生化复发发生率更低,1、5、10年生化复发无生存率在分级组≥2中分别为97.9% vs 85.5%、76.6% vs 65.1%、69.0% vs 54.2%(p=0.009),在分级组2中分别为96.4% vs 91.2%、89.6% vs 74.0%、89.6% vs 63.9%(p=0.071)。调整年龄、活检癌症范围和前列腺特异抗原密度后,分级组≥2的两组间生化复发风险无显著差异。

要点

  • 主动监测因分级升级至分级组≥2行根治术者生化复发发生率低于立即根治术者(p<0.05)。
  • 分级组≥2的1、5、10年生化复发无生存率主动监测组 vs 立即根治术组分别为97.9% vs 85.5%、76.6% vs 65.1%、69.0% vs 54.2%(p=0.009)。
  • 调整年龄、活检癌症范围和前列腺特异抗原密度后,分级组≥2的两组生化复发风险无显著差异。

核心结论

  • 主动监测中分级升级至分级组≥2的患者治疗失败风险不高于新诊断相似级别者。

研究设计与样本

  • 回顾性分析1995年至2015年在本机构接受手术的男性记录。
  • 主动监测组:因分级升级至Gleason 7(3+4)或更高(分级组≥2)行根治术94例,因分级升级至Gleason 7(3+4)(分级组2)行根治术56例。
  • 立即根治术组:诊断分级组≥2者3504例,分级组2者1979例。
  • 生化复发采用Kaplan-Meier分析和多变量Cox模型评估。

主要发现

  • 主动监测组生化复发发生率低于立即根治术组,活检分级组≥2和分级组2均p<0.05。
  • 活检分级组≥2的1、5、10年生化复发无生存率:主动监测组 vs 立即根治术组分别为97.9% vs 85.5%、76.6% vs 65.1%、69.0% vs 54.2%(p=0.009)。
  • 活检分级组2的1、5、10年生化复发无生存率:主动监测组 vs 立即根治术组分别为96.4% vs 91.2%、89.6% vs 74.0%、89.6% vs 63.9%(p=0.071)。
  • 活检分级组≥2中,调整年龄、活检癌症范围和前列腺特异抗原密度后,两组生化复发风险无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We compared biochemical recurrence between men on active surveillance who underwent radical prostatectomy triggered by grade reclassification and men diagnosed with similar grade disease treated with immediate radical prostatectomy. MATERIALS AND METHODS: We retrospectively analyzed the records of men who underwent surgery from 1995 to 2015 at our institution. We identified 4 groups, including 94 and 56 men on active surveillance who underwent radical prostatectomy following reclassification to Gleason 7 (3 + 4) or greater (grade groups 2 or greater) and Gleason 7 (3 + 4) (grade group 2), and 3,504 and 1,979 in the immediate prostatectomy group diagnosed with grade group 2 or greater and 2, respectively. Biochemical recurrence was assessed by Kaplan-Meir analysis and a multivariable Cox model. RESULTS: Men on active surveillance had a lower incidence of biochemical recurrence than men in the immediate radical prostatectomy groups for biopsy grade groups 2 or greater and 2 (each p <0.05). One, 5 and 10-year biochemical recurrence-free survival for men in the active surveillance group vs the immediate radical prostatectomy group was 97.9% vs 85.5%, 76.6% vs 65.1% and 69.0% vs 54.2% in biopsy grade groups 2 or greater (p = 0.009) and 96.4% vs 91.2%, 89.6% vs 74.0% and 89.6% vs 63.9%, respectively, in biopsy grade group 2 (p = 0.071). For biopsy grade groups 2 or greater there was no significant difference in the risk of biochemical recurrence between the groups after adjusting for age, biopsy extent of cancer and prostate specific antigen density. CONCLUSIONS: Patients on active surveillance reclassified to grade groups 2 or greater are at no greater risk for treatment failure than men newly diagnosed with similar grades.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Diniz CP, Landis P, Carter HB, et al. Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease. J Urol. 2017. PMID: 28347771. doi:10.1016/j.juro.2017.03.122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。